Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I102602-50mg | 50mg | In stock | $32.90 | |
I102602-100mg | 100mg | In stock | $47.90 | |
I102602-250mg | 250mg | In stock | $83.90 | |
I102602-1g | 1g | In stock | $234.90 |
Potent DNA topoisomerase I inhibitor
Synonyms | Irinotecan hydrochloride|100286-90-6|Irinotecan Hcl|Topotecin|Campto|Camptothecin 11 hydrochloride|Camptosar|CPT 11|CPT-11|Camptothecin 11|Irinotecan (hydrochloride)|U 101440E|UNII-06X131E4OE|CHEBI:5971|DTXSID6045953|06X131E4OE|(S)-4,11-diethyl-4-hydroxy- |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Irinotecan is a prodrug, which is converted to 7-ethyl-10-hydroxycamptothecin (SN-38), an effective inhibitor of DNA topoisomerase I, under the action of tissue carboxylesterase. The effect of UDP glucuronidase can be terminated by glucuronization. Irinot |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Irinotecan hydrochloride has been used: • in combination with 5-fluorouracil for screening growth inhibitory functionality in MDA-MB-231 breast cancer cells. • in chemosensitivity screening of high-grade appendiceal (HGA) and low-grade appendiceal (LGA) organoids. • as a chemotherapeutic agent in the cytotoxicity studies in combination with heat shock proteins inhibitors (HPSC1) in HT29 colon cancer cells. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488185009 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488185009 |
IUPAC Name | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride |
INCHI | InChI=1S/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1 |
InChi Key | GURKHSYORGJETM-WAQYZQTGSA-N |
Canonical SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl |
Isomeric SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl |
WGK Germany | 3 |
PubChem CID | 74990 |
Molecular Weight | 623.14 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2405484 | Certificate of Analysis | Jul 01, 2024 | I102602 |
L2315309 | Certificate of Analysis | Nov 27, 2023 | I102602 |
L2315308 | Certificate of Analysis | Nov 27, 2023 | I102602 |
G2326727 | Certificate of Analysis | Jul 04, 2023 | I102602 |
G2326737 | Certificate of Analysis | Jul 04, 2023 | I102602 |
G2326736 | Certificate of Analysis | Jul 04, 2023 | I102602 |
G2326734 | Certificate of Analysis | Jul 04, 2023 | I102602 |
G2326731 | Certificate of Analysis | Jul 04, 2023 | I102602 |
G2326725 | Certificate of Analysis | Jul 04, 2023 | I102602 |
B2302773 | Certificate of Analysis | Nov 14, 2022 | I102602 |
B2302870 | Certificate of Analysis | Nov 14, 2022 | I102602 |
B2302862 | Certificate of Analysis | Nov 14, 2022 | I102602 |
B2302836 | Certificate of Analysis | Nov 14, 2022 | I102602 |
B2302782 | Certificate of Analysis | Nov 14, 2022 | I102602 |
B2302774 | Certificate of Analysis | Nov 14, 2022 | I102602 |
H2222058 | Certificate of Analysis | Jul 18, 2022 | I102602 |
H2222059 | Certificate of Analysis | Jul 18, 2022 | I102602 |
H2222060 | Certificate of Analysis | Jul 18, 2022 | I102602 |
F1801026 | Certificate of Analysis | Apr 22, 2022 | I102602 |
F1801025 | Certificate of Analysis | Apr 22, 2022 | I102602 |
C2223340 | Certificate of Analysis | Mar 08, 2022 | I102602 |
Solubility | Soluble in DMSO or DMF at approximately 20mg/ml. Sparingly soluble in aqueous buffers. |
---|---|
Sensitivity | heat sensitive |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
WGK Germany | 3 |
Starting at $69.90